Literature DB >> 16327737

[Developing quality indicators in hospitals: the COMPAQH project].

C Grenier-Sennelier1, C Corriol, V Daucourt, P Michel, E Minvielle.   

Abstract

BACKGROUND: To select a set of quality indicators (QI) in order to test them in a panel of 36 French hospitals
METHODS: The COMPAQH (COordination for Measuring Performance and Assuring Quality in Hospitals) project is coordinated by the French National Institute for Medical Research and supported by the French Ministry of Health and the French National Evaluation and Accreditation Agency. This project has four objectives: (1) to select a set of QI -2003- (2) to implement them in 2004-2005 in a volunteer panel of hospitals (3) to compare the hospitals anonymously (4) to explore quality management implications. QI were selected with a four-step process: (1) Establishment of a list of national priorities for Quality Improvement in relation with the Ministry of Health. (2) setting up a potential list of QI regarding these priorities. The COMPAQH staff determined a preliminary set of 81 QI, based on data in the literature and evidence about the scientific soundness of quality measures and the effectiveness of methods for improving quality. (3) Evaluation of the preliminary list. Each QI was presented in a pamphlet describing its operational definition, rationale, methodology, workload and responsibility of data collection The hospital panel (representatives) ranked the 81 QI with a validated evaluation tool which contained four dimensions: Importance, Scientific acceptability, Feasibility, and Usability. (4) Development of a consensus on a final selection. Based on a structured voting process (Delphi method, two rounds), the hospital panel selected a comprehensive set of 42 QI among the 81.
RESULTS: (1) Eight national priorities were defined: pain management, continuity of care, management of nutritional disorders, Iatrogenic risks (including nosocomial infections), patient satisfaction, follow-up of practice guidelines, management of human resources, accessibility. (2) A set of 42 QI were selected: a set of 6 core QI and 7 to 18 specific QI according to the hospital type.
CONCLUSION: Such a set of QI provides a foundation for developing a quality measurement system in French hospitals. It requires a pragmatic view for implementing them and a coherence between the different objectives of use (internal and external use).

Entities:  

Mesh:

Year:  2005        PMID: 16327737

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  5 in total

1.  Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.

Authors:  Guillaume Hébert; Florence Netzer; Sylvain Landry Kouakou; François Lemare; Etienne Minvielle
Journal:  Int J Clin Pharm       Date:  2018-02-14

2.  Method for developing national quality indicators based on manual data extraction from medical records.

Authors:  Melanie Couralet; Henri Leleu; Frederic Capuano; Leah Marcotte; Gérard Nitenberg; Claude Sicotte; Etienne Minvielle
Journal:  BMJ Qual Saf       Date:  2012-09-26       Impact factor: 7.035

3.  Hospital quality measures: are process indicators associated with hospital standardized mortality ratios in French acute care hospitals?

Authors:  Marcus Ngantcha; Marie-Annick Le-Pogam; Sophie Calmus; Catherine Grenier; Isabelle Evrard; Agathe Lamarche-Vadel; Grégoire Rey
Journal:  BMC Health Serv Res       Date:  2017-08-22       Impact factor: 2.655

4.  How to limit the burden of data collection for Quality Indicators based on medical records? The COMPAQH experience.

Authors:  Clément Corriol; Valentin Daucourt; Catherine Grenier; Etienne Minvielle
Journal:  BMC Health Serv Res       Date:  2008-10-21       Impact factor: 2.655

5.  Building on the EGIPPS performance assessment: the multipolar framework as a heuristic to tackle the complexity of performance of public service oriented health care organisations.

Authors:  Bruno Marchal; Tom Hoerée; Valéria Campos da Silveira; Sara Van Belle; Nuggehalli S Prashanth; Guy Kegels
Journal:  BMC Public Health       Date:  2014-04-17       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.